0000950170-24-052874.txt : 20240503 0000950170-24-052874.hdr.sgml : 20240503 20240503160514 ACCESSION NUMBER: 0000950170-24-052874 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swisher Daniel N JR CENTRAL INDEX KEY: 0001323113 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 24912962 MAIL ADDRESS: STREET 1: C/O SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 ownership.xml 4 X0508 4 2024-05-01 0001088856 CORCEPT THERAPEUTICS INC CORT 0001323113 Swisher Daniel N JR C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 true false false false true Common Stock 2024-05-01 4 M false 2200 5.86 A 2200 D Common Stock 2024-05-01 4 S false 2200 23.09 D 0 D Stock option (right to buy) 5.86 2024-05-01 4 M false 2200 0 D 2026-07-21 Common Stock 2200 4550 D The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Fully exercisable. The power of attorney under which this form was signed is on file with the Commission. /s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr. 2024-05-03